|
Requirement :
|
Supply of drugs and dressings - 142b - antacid gel - each 5ml. to contain aluminium hydroxide 6g, mag. hydroxide 80mg., activated dimethicone 100mg., deglycycrrhizinated liquorice eqv. to liquorice 400mg., antacid gel - each 5ml contains dried aluminium hydroxide gel 300mg magnesium hydroxide 250mg, activated simethicone 40mg, antacid - each sachet (0.67g) contains water soluble azulene (sodium azulenesulfonate) jpc 2.01 mg l-glutamine jpc 663.3 mg, rabeprazole tab/cap - each tab/cap to contain rabeprazole 20 mg., ilaprazole tab/cap - each tab/cap to contain ilaprazole 10mg, esomeprazole tab/cap - each tab to contain esomeprazole magnesium 20 mg, esomeprazole tab/cap - each tab to contain esomeprazole magnesium 40 mg, pantaprazole 40mg + domperidone 30 mg sr tab - each tab/cap to contain pantaprazole 40mg + domperidone (sr) 30 mg, each uncoated tab/cap contains dried aluminium hydroxide i.p. 240 mg magnesium hydroxide i.p. 100 mg ,activated dimethicone i.p.... 25 mg, light magnesium carbonate i.p..... 60 mg., each 5ml contains aluminium hydroxide paste eqv. to dried aluminium hydroxide gel i.p-300 mg, magnesium hydroxide paste eqv. to magnesium hydroxide i.p-250 mg, activated dimethicone i.p-40mg, sorbitol solution i.p-1000mg, sucralfate 1 g susp - each 5 ml contain sucralfate 1 g, laxative liquid - each. 5 ml. to contain liquid parafin 1.25ml., milk of magnesia 3.75ml., sodium picosulphate 3.33mg., lactulose syp - each 15 ml. to contain lactulose 10gm., lactulose granules - each 15gm of granules to contain lactulose bp 10 gm, ispaghula husk ip 3.50 gm, laxative powder - each pouch to contain polyethylene glycol 118 gm, potassium chloride 1.484 gm, sodium bicarbonate 3.37 gm, sodium chloride 2.93 gm, sodium sulphate 11.36 gm., each sachet (17.1g) contains polyethylene glycol 4000 ip 14.6g, potassium chloride ip 0.18g, sodium chloride ip 0.36g, sodium bicarbonate ip 0.42g, anhydrous sodium sulphate bp 1.42g, activated dimethicone ip 0.01g, ondansetron tab/cap - each tab/cap to contain ondansetron 4mg., prochlorperazine tab/cap- each tab/cap to contain prochlorperazine maleate 5 mg., palonosetron hydrochloride inj - each 1.5 ml contains palonosetron hydrochloride equivalent to palonosetron-0.075 mg water for inj -q.s., drotaverine tab/cap - each tab/cap to containdrotavarine hcl 80 mg., hyoscine butyl bromide inj - each ml. to contain hyoscine butyl bromide 20mg., racecadotril dispersible tab/cap - each disp tab/cap to contain racecadotril 10mg, racecadotril dispersible tab/cap - each disp tab/cap to contain racecadotril 30 mg, furazolidone susp - each 5ml to contain furazolidone 25mg., metronidazole susp - each 5ml to containmetronidazole 200 mg., syrup zinc - each 5ml to contain elemental zinc 20mg, pre & prebiotic and oral rehydration - each pack-in- pack sachet who ors pack 4.10g contains sodium chloride 0.52gm,sodium citrate 0.58gm,potassium chloride 0.3gm,dextrose anhydrous 2.7gm pre & probiotic pack 0.5g contains streptococcus faecalis t- 110 7.5 million,clostridium butyricum to-a 0.5 million,bacillus mesentericus to-a 0.25 million,lactobacillus sporogenes 20.0 million., enzyme syp - each 15ml to contain iodised peptone 29 mg., mag. chl 20 mg., mang. sulph 4mg, zn. sulph. 6 mg., sod. metavandate 0.66 mg., pyridoxine hcl 0.75mg., cyanocobalamin 0.5mcg., nicotinamid 10mg. alcohol 0.95 ml., liver disorders syp. - each 10ml contain tricholine citrate 0.55gm, sorbitol 7.15gm., liver disorders syp - each 5ml to contain tricholine citrate 250 mg kalmegh ip eq. to andographolides 250mcg,sorbitrol-solution i.p. (70%) in a flavoured base, pre & probiotic tab/ cap. - each tab/cap. to contain streptococcus faecalis 30 million, clostridium butyricum 2 million, bacillus mesentericus 1 million, lactic acid bacillus sporogenes 50 mlllion., prebiotic and probiotic - each sachet (0.5gm) contains streptococcus faecalis t-110 30million clostridium butyricum to-a 2million bacillus mesentericus to a 1 million lactic acid bacillus 50 million (lactobacillus sporogenes), bacillus clausii spores susp. - each 5ml to contain bacillus clausii spores 2 billion spores, susp.in 5ml distilled water, pre & probiotic - each tab/cap.to contain streptocoocus faecalis t - 110 60 million, clostridium butyricum to-a 4 million, bacillus mesentericus to-a 2 million, lactic acid bacillus 100 million. (lactobacillus sporogenes), pre & probiotic dry syrup - each 5 ml to contains streptococcus faecalis t-110 30 million clostridium butyricum to-a 2 million bacillus mesentericus to-a 1 million lactic acid bacillus (lactobacillus sporogenes) 50 million excipients q.s., enzyme tab/cap - each cap to contain pepsin (13000) 12.5 mg., fungal diastase (12000) 18.75 mg., each 5 ml to contains essential phospholipids 250mg benzyl alcohol i.p. 45mg (preservative) water for injection i.p. q.s., each tab/cap contains lactobacillus plantarum lp 299v 10 billion cfu, each tab/cap contains2 billion spores of polyantibiotic- resistant bacillus clausii, each suppository to contains mesalazine 1 gm, each sachet to contains mesalazine 2 gm prolonged release granules, euphorbia prostata tab/cap - each tab/cap to contain euphorbia prostata dry extract ethanolic 80% (v/v) 100mg, haemorrhoidal cream - each gm to contain euphorbia prostrata dry extract ethanolic 80% (v/v) ((35-70)1) 10 mg (containing 0.315 -0.825 mg total flavonoids calcluated as apigenin-7 glucoside and 1.26-4.40 mg total phenolics calculated as gallic acid)cream base q.s., metoclopramide inj - each ml. to contain metoclopramide hcl. eqv. to metoclopramide 5 mg., ibuprofen oral susp. - each 5 ml. to contain ibuprofen 100 mg., paracetamol inj - each ml to contain paracetamol 10 mg, acetyl salicylic acid tab/cap - each enteric coated tab/cap to contain acetyl salicylic acid 150 mg., acetyl salicylic acid tab/cap - each enteric coated tab/cap to contain acetyl salicylic acid ip 325 mg., diacerein tab/cap. - each tab/cap. to contain diacerein 50mg., etoricoxib tab/cap - each tab/cap to contain etoricoxib 90 mg, naproxen tab/cap - each tab/cap to contain naproxen 250mg., allopurinol tab/cap - each tab/cap to contain allopurinol 100 mg., tramadol inj - each ml to containtramadol hydrochloride 50 mg., diclofenac 75mg iv inj - each 1ml to contain diclofenac 75mg iv, thiocolchicoside tab/cap. - each tab/cap to contain thiocolchicoside 8mg, tolperisone hcl tab/cap - each tab/cap to contain tolperisone hcl. 150 mg, tolperisone & diclofenac tab/cap - each film coated tab/cap to contain tolperisone hydrochloride jp 150mg, diclofenac sodium ip 50mg, excipients q.s, buprenorphine transdermal patch - each transdermal patch to contain buprenorphine 5 mcg/hr. area containing active substance 6.25sqcm, buprenorphine transdermal patch - each transdermal patch to contain buprenorphine 10 mcg/hr. area containing active substance 12.5sqcm, buprenorphine transdermal patch - each transdermal patch to contain buprenorphine 20 mcg/hr. area containing active substance 25sqcm, sodium hyaluronate inj (intra articular) - each pfs to contain sodium hyaluronate 25mg.,sodium chloride, sodium phosphate dibasic and monobasic qs, hylan g-f20 injection - each contain hylan g-f20, tocilizumab inj 80mg - each vial to contain tocilizumab 80 mg, tocilizumab inj 200mg - each vial to contain tocilizumab 200 mg, tocilizumab inj 400mg - each vial to contain tocilizumab 400 mg, analgesic gel - each gm. to contain nimesulide 10mg., methyl salicylate 100mg., menthol 50mg., capaicin 0.25mg.in cream base, analgesic cream - each contain cream methyl salicylate 8% w/w, mephenesin 5%w/w, methyl nicotinate 1% w/w, menthol 2% w/w, spray - containing spray diclofenac diethylmine 1.16%, methyl salicylate 10%w/w, linseed oil (oleum lini)-3% w/w, menthol 5% w/w, excipients & propellant q.s. 100 % w/w, teriparatide 750 mcg inj - each 3 ml cartridge to contain teriparatide 750 mcg, promethazine inj - each ml. to contain promet
|